Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan.
Institute of Population Health, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan.
Int J Mol Sci. 2020 Oct 31;21(21):8158. doi: 10.3390/ijms21218158.
Polyethylene glycol (PEG) coating of gold nanoparticles (AuNPs) improves AuNP distribution via blood circulation. The use of PEG-coated AuNPs was shown to result in acute injuries to the liver, kidney, and spleen, but long-term toxicity has not been well studied. In this study, we investigated reporter induction for up to 90 days in NF-κB transgenic reporter mice following intravenous injection of PEG-coated AuNPs. The results of different doses (1 and 4 μg AuNPs per gram of body weight), particle sizes (13 nm and 30 nm), and PEG surfaces (methoxyl- or carboxymethyl-PEG 5 kDa) were compared. The data showed up to 7-fold NF-κB reporter induction in mouse liver from 3 h to 7 d post PEG-AuNP injection compared to saline-injected control mice, and gradual reduction to a level similar to control by 90 days. Agglomerates of PEG-AuNPs were detected in liver Kupffer cells, but neither gross pathological abnormality in liver sections nor increased activity of liver enzymes were found at 90 days. Injection of PEG-AuNPs led to an increase in collagen in liver sections and elevated total serum cholesterol, although still within the normal range, suggesting that inflammation resulted in mild fibrosis and affected hepatic function. Administrating PEG-AuNPs inevitably results in nanoparticles entrapped in the liver; thus, further investigation is required to fully assess the long-term impacts by PEG-AuNPs on liver health.
聚乙二醇(PEG)包覆的金纳米粒子(AuNPs)通过血液循环改善 AuNP 的分布。已证明使用 PEG 包覆的 AuNPs 会导致肝脏、肾脏和脾脏的急性损伤,但长期毒性尚未得到很好的研究。在这项研究中,我们在静脉注射 PEG 包覆的 AuNPs 后,通过 NF-κB 转基因报告小鼠,对 90 天内的报告基因诱导进行了研究。比较了不同剂量(每克体重 1 和 4μgAuNPs)、粒径(13nm 和 30nm)和 PEG 表面(甲氧基-或羧甲基-PEG5kDa)的结果。数据显示,与生理盐水注射对照小鼠相比,PEG-AuNP 注射后 3 小时至 7 天,小鼠肝脏中的 NF-κB 报告基因诱导高达 7 倍,90 天逐渐降至对照水平。在肝库普弗细胞中检测到 PEG-AuNP 的聚集,但在 90 天时,肝切片中未发现明显的大体病理异常或肝酶活性增加。PEG-AuNP 的注射导致肝切片中胶原的增加和总血清胆固醇的升高,尽管仍在正常范围内,但表明炎症导致轻度纤维化并影响肝功能。PEG-AuNP 的给药不可避免地导致纳米粒子困在肝脏中;因此,需要进一步研究以充分评估 PEG-AuNP 对肝脏健康的长期影响。
Toxicol Appl Pharmacol. 2009-4-1
Nanomedicine (Lond). 2019-11-27
J Nanobiotechnology. 2024-5-13
Pharmaceutics. 2023-3-8
Comput Struct Biotechnol J. 2019-8-7
Semin Liver Dis. 2019-3-25
J Hepatol. 2019-2-21
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018-8-7
J Nanobiotechnology. 2018-2-6